LD-2 disclosure · 3rd Quarter - Report
CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Industry coalition to support antibiotic drug innovation
- Location
- District of Columbia · United States of America
Registrant
- Description
- Government and Public Affairs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Public policy to incentivize antibiotic drug development and innovation
LobbyistsDANIELLE ORGAN PETERS
TargetedSENATE · HOUSE OF REPRESENTATIVES
